Abstract:Background: Gout is most common inflammatory arthritis characterized by deposition of monosodium urate crystals in joints. Several genome-wide association studies (GWAS) have reported associations between common genetic variants and gout status. This study aimed to further elucidate the genetic architecture of gout for better understanding of pathogenesis. Methods: We conducted a large clinically defined gout GWAS in Chinese male descent (n case=3,669, n control=8,838) by using genome-wide genotyping arrays. Additional comprehensive analyses, including eQTL, pathway enrichment and connectivity enrichment analyses, were performed to further prioritize relevant genes, pathways and cell types that contributed to pathogenesis. The cell type intervention experiments were further performed in a MSU induced air-pouch mouse model of acute gouty arthritis to identify the role of different cell types in the gout pathogenesis. Findings: In addition to five previously reported urate- and gout-related loci, we detected four novel genome-wide significant (GWS, p<5.0×10-8) risk loci (1p35.2, 5q35.1, 7p13 and 22q12.3). For the GWS variants and their proxy (r 2 >0.8), 11 missense variants in 7 genes were identified, and eQTL analysis suggested involvement of MAPK signaling pathway. Genome-wide gene and gene-set analyses revealed novel gene and pathway associations (eg. T cell lineage commitment) with gout and also highlighted urate-related findings by single-SNP analysis. We also confirmed that CD4 T cell blockade can effectively alleviate the pathological process of gout. Interpretation: Our largest genome-wide data of clinically defined gout identified non urate-related associations at the variant, gene, pathway and cell type levels, and provided a better understanding of the pathogenesis of gout. Fundings: This work was supported by research project grants from National Natural Science Foundation of China, Shandong Province Key Research and Development Program, Taishan Scholar Program of Shandong Province, Shandong Province Natural Science Foundation, Shandong Provincial Science Foundation for Outstanding Youth Scholars, National Key R&D Program of China.Declaration of Interest: None declared.Ethical Approval: The study procedure complied with the Declaration of Helsinki and obtained ethical approval from the ethics committee of the Affiliated Hospital of Qingdao University.

Overview of multi-omics research in gout

The Role of Advanced Imaging in Gout Management

The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies

A genome-wide association analysis reveals new pathogenic pathways in gout*

Immune and inflammatory mechanisms and therapeutic targets of gout: An update

Metagenomic analysis revealed the potential role of gut microbiome in gout

Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms

A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout

Untargeted metabolomics analysis of the urinary metabolic signature of acute and chronic gout

Pathogenesis of gout: Exploring more therapeutic target

Unravelling the mysteries of gout by multimodality imaging

The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment

Advancements in the study of IL-6 and its receptors in the pathogenesis of gout

Recent Advances in Gout Drugs

Gout and Diet: A Comprehensive Review of Mechanisms and Management

Gout: state of the art after a decade of developments

GWAS of Clinically Defined Gout Identifies Non-Urate-Related Loci and Implicates Novel Gene, Pathway and Cell Type Associations

TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter

Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout

From Patents to Progress: Unraveling Gout's Journey Through Clinical Trials and Advancements

Contributions of joint damage-related events to gout pathogenesis: new insights from laboratory research